Browse articles from EyeWorld.org related to refractive surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

Piggyback IOLs an important tool for postop precision

While laser vision correction and IOL exchange remain the preferred methods for correcting residual refractive error, two ophthalmologists said there is still a place for piggyback IOLs. They spoke about when they would consider a piggyback IOL, their preferred lenses, and their thoughts on newer generation IOL options.

Comments Off on Piggyback IOLs an important tool for postop precision

EyeWorld Weekly, October 3, 2025

➤ Phase 1/2 trial update for Leber congenital amaurosis gene therapy in pediatric patients ➤ Primary endpoint not met in Phase 2b trial investigating persistent corneal epithelial defect treatment ➤ Study: treatment for uveal melanoma could improve survival rate ➤ Company news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, October 3, 2025

Going beyond the routine

“Even with the wealth of new technologies available … refractive surprises, longer and shorter eyes, and unique medical histories persist. During these times we are called to flex our expertise and go beyond the routine to meet the needs of these patients,” said Karolinne Rocha, MD, introducing the articles in the Refractive section.

Comments Off on Going beyond the routine

EyeWorld Weekly, August 22, 2025

➤ Phase 2 trial is the ‘first and only’ to show vision improvement for Stargardt disease ➤ IND accepted for retinal disease gene therapy and Phase 1/2 trial to begin ➤ First patients dosed in trial evaluating retinitis pigmentosa treatment ➤ LASIK alternative being researched ➤ Partnership news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, August 22, 2025

EyeWorld Weekly, June 6, 2025

➤ FDA approves first-in-class DED drop ➤ FDA accepts NDA for topical presbyopia therapy ➤ TFOS DEWS III ➤ Topline results in Phase 3 study evaluating night driving impairment after keratorefractive surgery ➤ IND application submitted for pediatric myopia treatment ➤ Study sheds light on clinical inherited retinal diseases without genetic mutations ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, June 6, 2025

EyeWorld Weekly, February 7, 2025

➤ FDA approves continuous delivery treatment for DME ➤ Positive topline data from Phase 2 trials for new glaucoma treatment ➤ Positive 6-month data from clinical trial evaluating drug delivery for treatment of DME ➤ Pivotal study evaluating AI algorithm for neovascular AMD with home OCT published ➤ Regenerative Medicine Advanced Therapy designation granted to X-linked retinitis pigmentosa treatment ➤ Promising results for ophthalmic gel to treat geographic atrophy ➤ Recruitment complete in trial for continuous range-of-vision IOL ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, February 7, 2025

ASCRS hosts inaugural BRiCS Summit

The ASCRS Business of Refractive Cataract Surgery (BRiCS) Summit, which took place September 27–28 in Irving, Texas, brought together practice teams to emphasize the fact that for advanced-technology IOL adoption to be successful, all members of the practice need to be educated on various aspects.

Comments Off on ASCRS hosts inaugural BRiCS Summit